Last reviewed · How we verify

NCT04336358

Telemedicine for First Trimester Abortion in South Africa

Status unknown NA Last updated 30 April 2021
What this trial tests

NA trial testing Telemedicine in Abortion in First Trimester in 900 participants. Status unknown.

Timeline
27 February 2020
Primary endpoint
30 September 2021
15 November 2021

Quick facts

Lead sponsorUniversity of Cape Town
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment900
Start date27 February 2020
Primary completion30 September 2021
Estimated completion15 November 2021
Sites4 locations across South Africa

Drugs / interventions tested

Conditions studied

Sponsor

University of Cape Town

Who can join

Adults 18 to 44, female only, with Abortion in First Trimester. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aim to determine if medical abortion facilitated by a physician online (s.c. telemedicine), combined with a simplified physical exam, is equally effective, safe and acceptable to women in South Africa as standard medical abortion care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
    Endler M, Petro G, Gemzell Danielsson K, Grossman D, et al · · 2022 · cited 23× · PMID 36030811 · DOI 10.1016/s0140-6736(22)01474-x

Verify or expand the search:

Other trials of Telemedicine

Trials testing the same drug.

Other recruiting trials for Abortion in First Trimester

Currently open trials in the same condition.

Other University of Cape Town trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04336358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing